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The aim of this study was to determine the effect of opium on hypothalamic 
pituitary gonad function. Fifty-six opium dependent (28 men and 28 women; 
mean age, 25±5 year) were enrolled for hypothalamic pituitary gonadal axis. 
The control group considered of 56 non-opium dependent subject (28 men and 
28 women; mean age 25±5 year). Decreased libido or impotency was present in 
26 of 28 opium dependent men. The serum testosterone level was below 
9 rnnol L -i in 24 of 28 men and was significantly lower than that in the control 
group (p<0.001). The free androgen index was below normal in 16 of 28 men and 
was significantly lower tlian tliat in tlie control group (p<0.001 ). Tlie serum LH 
level was less than 2 U L -i in 17 of 28 men significantly lower than that in the 
control group (p<0.001 ). Serum FSH was normal in both groups. Decreased libido 
was present in 16 of 28 women opium dependent. Serum LH, estradiol and 
progesterone levels were lower in opium group. In conclusion, of all opium 
addicts the large majority of men and all of women developed hypogonadotropic 
hypogonadism. The results reveal that opium can extract deleterious actions upon 
male and female hypothalamic pituitary gonadal axis and these findings suggested 
that further investigations are required to determine the need for endocrine 
work-up in opium dependent and the important substitutive therapy. 
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INTRODUCTION 
Opium, smoked for centuries in the repursuit of 
pleasure, was quickly recognized as providing relief 
of subjective discomfort. Opium contains more than 
20 distinct alkaloids, the first of which (morphine) isolated 
in 1806. Many semi synthetic derivatives are made by 
relatively simple modifications of major opium alkaloids, 
morphine or thebaine. Thebaine has little analgesic action 
but is a precursor of several important compounds, such 
as oxycodone. In addition to morphine, codeine and the 
semi synthetic derivatives of the natural opium alkaloids, 
a number of other structurally distinct chemical classes of 
drugs have pharmacological actions similar to those of 
morphine (Susan and Thomas, 1999). Opioid peptides are 
found throughout the central nervous system. Both acute 
and chronic neuroendocrine effects of opiates and 
different opioid peptides have been studied extensively in 
animals and humans. In humans the acute administration 
of opioids decreases LH release (Morley, 1981; Grossman, 
1983; Abs and Verhelst, 2000). The restraint on LH release 
is predominantly mediated through central inhibition of 
hypothalamic GnRH secretion (Rasusmussen and Liu, 
1983). It is possiblethat ~END may be an indirect modifier 
(via Sertoli cells) of Ley dig cell steroidogenic activity. In 
accordance with this hypothesis the observation that 
~END significantly inhibits FSH in rats (Morris et al., 
1987). It must be noted that exogenous opioids are direct 
stimulantof ~END receptors in adult rat testis (Adams and 
Cicero, 1991; Adams et al., 1991) and it has been 
suggested that opioids may act through testicular ~END 
to suppress the synthesis and release of testosterone 
(Adams et al., 1991 ). Exposure to opioids for 3 days 
caused asignificant increase in [3H] etorphine specifically 
bound to the Sertoli cells (Fabbri and Morris, 1985). 
Taking in to accollllt the receptor subtypes, TSH is 
preferentially activated by receptors and the inhibitory 
control ofLH involves receptors (Delitala and Grossman, 
1983; Grossman and Moult, 1986). Despite the fact that 
opioids are knovvn to control or influence several 
endocrine pathways (Morley, 1981 ), no studies have 
looked systemically for possible hypothalamic pituitary 
gonadal axis changes induced by opium dependency. 
Therefore, we thoroughly studied the hypothalamic 
pituitary gonadal axis of large group opium addict and 
compared these results to the data obtained from a control 
group of non-opium dependent subjects. 
MATERIALS AND METHODS 
Patients: Total 56 opium dependent with a mean age of 
25±5 year was enrolled in this case-control study they 
consisted of 28 males and 28 females. They all suffered 
opium dependency that they referred to Rahaee addiction 
up clinic of Zabol of Iran in 2004. No subject had been 
given corticosteroids during the previous 6 months. The 
mean duration of opium dependency at the time of 
analysis was 5±2 year. adverse events related to 
opium dependency were actively sought, in particular 
the sexual history. 
Control population: The control group considered of 
28 male with mean age 25±5 year and 28 female 
with the same age. 
For all patients and controls the following 
variables were recorded: gender, age, body mass index, 
blood pressure. 
The gonadal axis was evaluated by determining 
serum estradiol and progesterone in females and by 
determining serum testosterone and sex hormone binding 
globulin (SHBG) and calculating the free androgen index 
(FAI~ Testosterone/SHBG) in males. 
LH and FSH were measured twice with a 15-min 
interval between measurements and the lowest value 
was chosen to avoid a peak due to pulsatile secretion 
(Abs and Verhelst, 2000). 
Differences between groups were tested for 
significance using Student t test p<0.001 was considered 
statistically significant. 
RESULTS AND DISCUSSION 
No differences were folllld between the opium 
dependant group and the control group for following 
parameters: gender, age, body mass index, blood 
pressure (Table 1 ). 
Twenty six of 28 males from the opium dependent 
group, retrospectively considered libido as normal before 
opium dependency, whereas 25 of 28 control group had 
no sexual complaints. Twenty of 26 males 76.9% reported 
a rather sudden decrease and even disappearance of 
libido and potency shortly after initiating opium abuse. 
Serum testosterone (p<0.001) and F AI (p<0.001) were 
significantly lower in the opium dependent group 
compared to the control group. 
The serum LH concentration was significantly lower 
in opium dependent group (p<0.001). Seventeen of the 
Table 1: Clinical characteristics of groups 
Parameters Opium group Control group p-value 
No. 56 56 NS 
Gender 23M/23F 23M/23F NS 
Age fyear) 25±5 25±5 NS 
Systolic pressure (mmHg) 125.3±11.3 110±12.5 NS 
Diastolic pressure (mmHgl 80±5.5 75.0±8 NS 
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Table 2: Pituit onadal axis in OU ~ 
Normal Values OQium grouQ Control grouQ Q-value 
Males 28 28 
Testosterone (nmol L- 1) 9-26 5.5±4.9 16±4 <0.001 
Free androgen Index 20-80 22.5±19.6 50±18.7 <0.001 
LH(UL-1) 2-9 1.3±0.9 5.3±3.3 <0.001 
FSH(UL-1) 2-7 4.3±2 6.0±3.9 NS 
Females 28 28 
Pre menopausal Females 16 10 NS 
LH(UL-1) 2-8 2.1±186 14±13.2 NS 
FSH(UL-1) 2-8 6.0±5.0 8.9±8.5 NS 
Estradiol (pmol) 110-800 130±118 356±390.3 NS 
Progesterone (pmol) 3-60 2±2.3 8.6±11.0 NS 
Post menopausal Females 12 18 NS 
LH(UL-1) >13 4.1±3.6 27.0±13.8 <0.001 
FSH(UL-1) >38 15.0±16.4 37±21.3 0.015 
Estradiol (pmol) <110 105±116.7 55.9±37.4 NS 
Pro esterone mo! >3 1.3±0.7 1.6±0.4 NS 
28 male opium dependent ( 60.7%) and one control subject 
had a LH level less than 2.0 U L - 1. There were no 
differences in serum FSH between the groups. Four of 
the 28 (14.2%) male opium dependents and no control 
patients had a FSH level less than 2.0 UL- 1. Sixteen of 
28 women opium libido as normal before opium 
dependency the start of opium use. Libido decreased or 
disappeared shortly after initiating opium dependency 
in 10of16 women (62.5%). 
Serum LH, FSH, estradiol and progesterone were 
clearly lower in the opium group than in the control group. 
Seven of the 16 pre menopausal opium dependents 
(43.7%) and no control subject showed a LH level less 
than 2 UL- 1. Four of the 16 pre menopausal opium group 
(25%) and no control women showed a FSH level less 
than 2 UL_,. 
In the 12 post menopausal women, serum LH 
(p<0.001) andFSH concentrations were significantly lower 
than those in the 5 post menopausal control women. 
All 12 post menopausal opium dependents (I 00%) and no 
control individuals showed a LH level less than 13 UL-l. 
Ten of the 12 post menopausal opium group (83.3%) and 
one control individuals showed a FSH level less than 
38 UL_, (Table 2). 
Opium, smoked for centuries in the repursuit of 
pleasure, was quickly recognized as providing relief of 
subjective discomfort (Susan and Thomas, 1999). Opium 
dependence is an important health problem and opium is 
traditional drug for abuse and addiction in Iran. In this 
case-control study we were able clearly demonstrate that 
opium dependency my have profolllld effects on 
hypothalamic pituitary gonad fllllction. The present 
results showed a clear and significant suppression of LH 
and testosterone in virtually all males and a similar 
decrease in LH secretion with a disrupted menstrual cycle 
in females. Despite the significant difference in LH, 
estradiol and progesterone levels in premenopausal 
women, was significant. Opioid peptides are folllld 
throughout the central nervous system. Endogenous 
opiates play a major role in the regulation of 
gonadotropines, especially LH, through a tonic inhibitory 
control and probably a minor acute neuromodulatiory role 
in the stimulatory regulation of TSH. This is in 
contradistinction with the rate in which endogenous 
opiates appear to have a much more significant effect on 
TSH (Morley, 1981 ). Both acute and chronic 
neuroendocrine effects of opiates and different opioid 
peptides have been studied decreases LH release 
(Morley, 1981; Grossman, 1983; Abs and Verhelst, 2000). 
The restraint on LH release is predominantly mediated 
through central inhibition of hypothalamic GnRH 
secretion (Rasusmussen and Liu, 1983). Reduced libido 
is a well-known phenomenon for those using heroin or in 
methadone maintenance program. Animal studies confirm 
that opioids lower testosterone levels and suppress 
sexual fllllction in males (Celani et al., 1984). Early case 
studies of persons using heroine or methadone described 
diminished libido, sexual dysfllllction, reduced 
testosterone levels men and amenorrhea in women 
(Lafisca et al., 1981; Mendelson et al., 1975). Two 
mechanisms are thought to be responsible for the 
reported reduction in libido associated with opioid use. 
Opioids inhibit the production of gonadotropin releasing 
hormone, subsequently decreasing the release of 
Luteinizing Hormone (LH), thus and decreasing the 
production of testosterone. Opioids also produce 
hyperprolactinemia, which causes negative feedback on 
the release of LH and decreases the production of 
testosterone (Ragni et al., 1985). Opioids are knovvn to 
alter the normal fllllction of hypothalamic pituitary 
gonadal axis (Wang et al., 1978). More recent case reports 
of patients receiving opioids for relief of chronic pain 
suggest these same findings (Abs and Verhelst, 2000). 
Although the limited research that has examined the 
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relationships among sexual fllllctioning, chronic pain, 
opioid therapy and testosterone levels has been 
predominantly evaluated in men, anecdotal clinical 
experience supports similar relationship in women. Recent 
empirical support has been documented for women in a 
study that examined the endocrine consequences of 
long-term intrathecal administration of opioids. Reduced 
libido was reported in 95 percent of men and 68 percent of 
women, with significant reduction in serum LH for both 
groups and serum testosterone for the men all of 
the premenopausal women (n=21) developed either 
amenorrhea or an irregular menstrual cycle with ovulation 
in only one women (Abs and Verhelst, 2000). All above 
studies and data are paralleled with this study. Thus we 
argue that these findings should be taken in to accollllt in 
all opium dependent subjects and endocrine check up is 
necessary. 
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